Growth Retardation in Offspring of Female Rats Treated with Morphine Prior to Conception-Reference-Cited by-同舟云学术

Growth Retardation in Offspring of Female Rats Treated with Morphine Prior to Conception

Published:1972-02-11 Issue:4022 Volume:175 Page:654-656
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Friedler Gladys¹,Cochin Joseph²

Affiliation:

1. Department of Pharmacology, Harvard Medical School, and Department of Anesthesia, Boston Hospital for Women, Boston, Massachusetts 02115

2. Department of Pharmacology, Boston University School of Medicine, Boston, Massachusetts 02118

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference32 articles.

1. BARRACLOUGH, C.A., INHIBITION OF THE RELEASE OF PITUITARY OVULATORY HORMONE IN THE RAT BY MORPHINE, ENDOCRINOLOGY 57: 329 (1955).

2. COCHIN, J, POSSIBLE MECHANISMS IN DEVELOPMENT OF TOLERANCE, FEDERATION PROCEEDINGS 29: 19 (1970).

3. COCHIN, J, DEVELOPMENT + LOSS OF TOLERANCE TO MORPHINE IN RAT AFTER SINGLE + MULTIPLE INJECTIONS, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 145: 1 (1964).

4. COCHIN, J, RESEARCH PUBLICATIONS. ASSOCIATION FOR RESEARCH IN NERVOUS AND MENTAL DISEASE 46: 268 (1968).

5. COHEN, M, EFFECT OF ACTINOMYCIN D ON MORPHINE TOLERANCE, PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 119: 381 (1965).

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developmental outcomes with perinatal exposure (DOPE) to prescription opioids;NeuroImmune Pharmacology and Therapeutics;2023-11-27

2. Morphine Perinatal Exposure Induces Long-Lasting Negative Emotional States in Adult Offspring Rodents;Pharmaceutics;2021-12-24

3. Passive Addiction and Teratogenic Effects;Volpe's Neurology of the Newborn;2018

4. Epigenomic and Noncoding RNA Regulation in Addictive Processes;Environmental Epigenomics in Health and Disease;2013

5. Methadone and Metabolites in Hair of Methadone-Assisted Pregnant Women and Their Infants;Therapeutic Drug Monitoring;2012-06